295 related articles for article (PubMed ID: 17500064)
1. Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle.
Krämer DK; Al-Khalili L; Guigas B; Leng Y; Garcia-Roves PM; Krook A
J Biol Chem; 2007 Jul; 282(27):19313-20. PubMed ID: 17500064
[TBL] [Abstract][Full Text] [Related]
2. The PPARdelta agonist, GW501516, promotes fatty acid oxidation but has no direct effect on glucose utilisation or insulin sensitivity in rat L6 skeletal muscle cells.
Dimopoulos N; Watson M; Green C; Hundal HS
FEBS Lett; 2007 Oct; 581(24):4743-8. PubMed ID: 17869249
[TBL] [Abstract][Full Text] [Related]
3. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
[TBL] [Abstract][Full Text] [Related]
4. Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta.
Krämer DK; Al-Khalili L; Perrini S; Skogsberg J; Wretenberg P; Kannisto K; Wallberg-Henriksson H; Ehrenborg E; Zierath JR; Krook A
Diabetes; 2005 Apr; 54(4):1157-63. PubMed ID: 15793256
[TBL] [Abstract][Full Text] [Related]
5. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARδ-dependent pathways in skeletal muscle of mice.
Jung TW; Lee SH; Kim HC; Bang JS; Abd El-Aty AM; Hacımüftüoğlu A; Shin YK; Jeong JH
Exp Mol Med; 2018 Sep; 50(9):1-11. PubMed ID: 30213948
[TBL] [Abstract][Full Text] [Related]
6. In vitro responsiveness of human muscle cell peroxisome proliferator-activated receptor δ reflects donors' insulin sensitivity in vivo.
Ordelheide AM; Heni M; Thamer C; Machicao F; Fritsche A; Stefan N; Häring HU; Staiger H
Eur J Clin Invest; 2011 Dec; 41(12):1323-9. PubMed ID: 21615395
[TBL] [Abstract][Full Text] [Related]
7. Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist.
Sprecher DL; Massien C; Pearce G; Billin AN; Perlstein I; Willson TM; Hassall DG; Ancellin N; Patterson SD; Lobe DC; Johnson TG
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):359-65. PubMed ID: 17110604
[TBL] [Abstract][Full Text] [Related]
8. The PPARδ Agonist GW501516 Improves Lipolytic/Lipogenic Balance through CPT1 and PEPCK during the Development of Pre-Implantation Bovine Embryos.
Idrees M; Xu L; El Sheikh M; Sidrat T; Song SH; Joo MD; Lee KL; Kong IK
Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810173
[TBL] [Abstract][Full Text] [Related]
9. Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.
Al-Khalili L; Bouzakri K; Glund S; Lönnqvist F; Koistinen HA; Krook A
Mol Endocrinol; 2006 Dec; 20(12):3364-75. PubMed ID: 16945991
[TBL] [Abstract][Full Text] [Related]
10. Treatment with PPARδ agonist alleviates non-alcoholic fatty liver disease by modulating glucose and fatty acid metabolic enzymes in a rat model.
Li X; Li J; Lu X; Ma H; Shi H; Li H; Xie D; Dong L; Liang C
Int J Mol Med; 2015 Sep; 36(3):767-75. PubMed ID: 26133486
[TBL] [Abstract][Full Text] [Related]
11. PPARδ activation in human myotubes increases mitochondrial fatty acid oxidative capacity and reduces glucose utilization by a switch in substrate preference.
Feng YZ; Nikolić N; Bakke SS; Boekschoten MV; Kersten S; Kase ET; Rustan AC; Thoresen GH
Arch Physiol Biochem; 2014 Feb; 120(1):12-21. PubMed ID: 23991827
[TBL] [Abstract][Full Text] [Related]
12. AMP-Activated Protein Kinase Interacts with the Peroxisome Proliferator-Activated Receptor Delta to Induce Genes Affecting Fatty Acid Oxidation in Human Macrophages.
Kemmerer M; Finkernagel F; Cavalcante MF; Abdalla DS; Müller R; Brüne B; Namgaladze D
PLoS One; 2015; 10(6):e0130893. PubMed ID: 26098914
[TBL] [Abstract][Full Text] [Related]
13. PPARδ agonists have opposing effects on insulin resistance in high fat-fed rats and mice due to different metabolic responses in muscle.
Ye JM; Tid-Ang J; Turner N; Zeng XY; Li HY; Cooney GJ; Wulff EM; Sauerberg P; Kraegen EW
Br J Pharmacol; 2011 Jun; 163(3):556-66. PubMed ID: 21265823
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor δ improves porcine blastocyst hatching via the regulation of fatty acid oxidation.
Guo J; Lu WF; Liang S; Choi JW; Kim NH; Cui XS
Theriogenology; 2017 Mar; 90():266-275. PubMed ID: 28166979
[TBL] [Abstract][Full Text] [Related]
15. Activation of PPAR-delta in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids.
Brunmair B; Staniek K; Dörig J; Szöcs Z; Stadlbauer K; Marian V; Gras F; Anderwald C; Nohl H; Waldhäusl W; Fürnsinn C
Diabetologia; 2006 Nov; 49(11):2713-22. PubMed ID: 16960684
[TBL] [Abstract][Full Text] [Related]
16. Angiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubes.
Robciuc MR; Skrobuk P; Anisimov A; Olkkonen VM; Alitalo K; Eckel RH; Koistinen HA; Jauhiainen M; Ehnholm C
PLoS One; 2012; 7(10):e46212. PubMed ID: 23056264
[TBL] [Abstract][Full Text] [Related]
17. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
[TBL] [Abstract][Full Text] [Related]
18. PPARdelta activator GW-501516 has no acute effect on glucose transport in skeletal muscle.
Terada S; Wicke S; Holloszy JO; Han DH
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E607-11. PubMed ID: 16278250
[TBL] [Abstract][Full Text] [Related]
19. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome.
Tanaka T; Yamamoto J; Iwasaki S; Asaba H; Hamura H; Ikeda Y; Watanabe M; Magoori K; Ioka RX; Tachibana K; Watanabe Y; Uchiyama Y; Sumi K; Iguchi H; Ito S; Doi T; Hamakubo T; Naito M; Auwerx J; Yanagisawa M; Kodama T; Sakai J
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15924-9. PubMed ID: 14676330
[TBL] [Abstract][Full Text] [Related]
20. Protective Effect of Unsaturated Fatty Acids on Palmitic Acid-Induced Toxicity in Skeletal Muscle Cells is not Mediated by PPARδ Activation.
Tumova J; Malisova L; Andel M; Trnka J
Lipids; 2015 Oct; 50(10):955-64. PubMed ID: 26255030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
